Research continues despite impact of funding deficit

Article

A lack of dependable funding is threatening to create a deficit of highly skilled scientists at a time when the U.S. could face a health care crisis brought on by devastating disorders, according to results of a recent study.

Clarksburg, MD-BrightFocus Foundation has released the results of a survey of more than 170 biomedical scientists that explores the most significant barriers to progress in ending eye and brain diseases.

The survey indicates that a lack of dependable funding is threatening to create a deficit of highly skilled scientists at a time when the nation could soon face a health care crisis brought on by devastating disorders such as Alzheimer’s, macular degeneration, and glaucoma.

“Nearly 20 million people in the U.S. are affected by Alzheimer’s disease, macular degeneration, or glaucoma. That number is climbing with an aging population, threatening our families, our health care, and our economy. Eradicating these diseases should be a much higher national priority,” said Stacy Haller, president and chief executive officer of BrightFocus Foundation, formerly named American Health Assistance Foundation.

For details of the survey and results, go to www.brightfocus.org/ResearcherSurvey2013.

Recent Videos
In 2 weeks, the study participant's dry eye symptoms improved from 76 to 43 on a 0-100 rating scale, according to Marc-Matthias Schulze, PhD, Dipl Ing.
Eye care practitioners reported moderate to high satisfaction with lifitegrast's ability to improve signs of dry eye, according to Melissa Barnett, OD, FAAO, FSLS.
Neda Gioia, OD, CNS, FOWNS, details the positive feedback gained so far from other optometrists that have been prescribing the NutriTears supplement to their dry eye patients.
Damaris Raymondi, OD, FAAO, highlighted the importance of building patient-doctor trust to learn about these practices, which can include non-traditional treatments like chamomile or manuka honey eye drops.
Noreen Shaikh, OD, Magdalena Stec, OD, FAAO, and Brenda Bohnsack, MD, PhD, emphasize that collaboration and communication are key to proper diagnosis and treatment.
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
Kerry Giedd, OD, MS, FAAO, was 1 of 20 investigators around the country for a study evaluating the daily disposable contact lens.
According to A. Paul Chous, MA, OD, FAAO, optometrists have an important opportunity to educate patients in their chairs about diabetes.
David Geffen, OD, FAAO, gave a poster presentation titled "Revolutionizing Comfort: Unveiling the Potential of Perfluorohexyloctane Eyedrops for Contact Lens Wearers" at this year's Academy meeting.
Jessica Steen, OD, FAAO, Dipl-ABO, discussed ophthalmic considerations for patients undergoing treatment with antibody drug conjugates for gynecologic cancers at this year's conference.
© 2024 MJH Life Sciences

All rights reserved.